The dopamine transporter: Immunochemical characterization and localization in brain

Journal of Neuroscience

Volumn 15, Issue 3 I, 1995, Pages 1714-1723

  Ciliax, Brian J ^a   Heilman, Craig ^a   Demchyshyn, Lidia L ^b   Pristupa, Zdenek B ^b   Ince, Ernesto ^a   Hersch, Steven M ^a   Niznik, Hyman B ^b   Levey, Allan I ^a,b,c  

^a EMORY UNIVERSITY   (United States)

^b CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

antibody; brain; dopamine transporter; immunoblot; immunocytochemistry; immunoprecipitation; local ization

Indexed keywords

AMINO TERMINAL SEQUENCE; ANTIBODY SPECIFICITY; ANTIGEN RECOGNITION; ARTICLE; CELL FUSION; DOPAMINERGIC TRANSMISSION; IMMUNOBLOTTING; IMMUNOCHEMISTRY; IMMUNOPRECIPITATION; INNERVATION; MENTAL DISEASE; NONHUMAN; PRIORITY JOURNAL; TISSUE DISTRIBUTION;

EID: 0028936065     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.15-03-01714.1995     Document Type: Article

References (47)

1. Allard P, Marcusson JO, Ross SB (1994) [3H]GBR-12935 binding to cytochrome P450 in the human brain. J Neurochem 62:342-348.
2. Arluison M, Dietl M, Thibault J (1984) Ultrastructural morphology of dopaminergic nerve terminals and synapses in the striatum of the rat using tyrosine hydroxylase immunocytochemistry: a topographical study. Brain Res Bull 13:269-285.
3. Boja JW, Vaughan R, Patel A, Shaya EK, Kuhar MJ (1994) The dopamine transporter. In: Dopamine receptors and transporters: pharmacology, structure, and function (Niznik HB, ed), pp 611-644. New York: Dekker.
4. Cerruti C, Walther DM, Kuhar MJ, Uhl GR (1993) Dopamine transporter mRNA expression is intense in rat midbrain neurons and modest outside midbrain. Brain Res Mol Brain Res 18:181-186.
5. 3H]mazindol. Neuroscience 49:317-327.
6. Ciliax BJ, Hersch SM, Levey AI (1994) Immunocytochemical localization of D1 and D2 receptors in rat brain. In: Dopamine receptors and transporters: pharmacology, structure, and function (Niznik HB ed), pp 383-399. New York: Dekker.
7. Ciliax BJ, Heilman C, Edmunds S, Hersch SM, Levey AI (1995) Antifusion protein antibodies specific for receptor subtypes. In: Methods in neurosciences, Vol 25, Receptor molecular biology (Sealfon SC, ed). Orlando: Academic.
8. 3H]mazindol autoradiography. Brain Res 504:64-71.
9. 3H] mazindol autoradiography. J Comp Neurol 304:419-434.
10. Freund TF, Powell JF, Smith AD (1984) Tyrosine hydroxylase-immunoreactive boutons in synaptic contact with identified striatonigral neurons, with particular reference to dendritic spines. Neuroscience 13:1189-1215.
11. Fuxe K, Agnati LF, Kalia M, Goldstein M, Andersson K, Härfstrand A (1985) Dopaminergic systems in the brain and pituitary. In: The dopaminergic system (Flückiger E, Müller EE, Thorner MO, eds), pp 11-25 New York: Springer Sandoz.
12. Garris PA, Wightman RM (1994) Different kinetics govern dopaminergic transmission in the amygdala, prefrontal cortex, and striatum: an in vivo voltammetric study. J Neurosci 14:442-450.
13. Gerfen CR, Baimbridge KG, Thibault J (1987) The neostriatal mosaic: III. Biochemical and developmental dissociation of patch-matrix mesostriatal systems. J Neurosci 7:3935-3944.
14. Giros B, Caron MG (1993) Molecular characterization of the dopamine transporter. Trends Pharmacol Sci 14:43-49.
15. Giros B, el MS. Bertrand L, Caron MG (1991) Cloning and functional characterization of a cocaine-sensitive dopamine transporter. FEBS Lett 295:149-154.
16. Giros B, el MS, Godinot N, Zheng K, Han H, Yang FT, Caron MG (1992) Cloning, pharmacological characterization, and chromosome assignment of the human dopamine transporter. Mol Pharmacol 42: 383-390.
17. Graybiel AM, Moratalla R (1989) Dopamine uptake sites in the striaturn are distributed differentially in striosome and matrix compartments. Proc Natl Acad Sci USA 86:9020-9024.
18. Graybiel AM, Hirsch EC, Agid YA (1987) Differences in tyrosine hydroxylase-like immunoreactivity characterize the mesostriatal innervation of striosomes and extrastriosomal matrix at maturity. Proc Natl Acad Sci USA 84:303-307.
19. Graybiel AM, Moratalla R, Quinn B, DeLanney LE, Irwin I, Langston JW (1993) Early-stage loss of dopamine uptake-site binding in MPTP-treated monkeys. Adv Neurol 60:34-39.
20. Kalsbeek A, Voorn P, Buijs RM, Pool CW, Uylings HB (1988) Development Of the dopaminergic innervation in the prefrontal cortex of the rat. J Comp Neurol 269:58-72.
21. 3H]dopamine is taken up and released from nondopaminergic nerve terminals in the rat substantia nigra m vitro. J Neurochem 45:137-144.
22. Kopin IJ, Markey SP (1988) MPTP toxicity: implications for research in Parkinson's disease. Annu Rev Neurosci 11:81-96.
23. Levey AI, Hersch SM, Rye DB, Sunahara RK, Niznik HB, Kitt CA, Price DL, Maggio R, Brann MR, Ciliax BJ (1993) Localization of D1 and D2 dopamine receptors in brain with subtype-specific antibodies. Proc Natl Acad Sci USA 90:8861-8865.
24. Lew R, Grigoriadis D, Wilson A, Boja JW, Simantov R, Kuhar MJ (1991) Dopamine transporter: deglycosylation with exo- and endoglycosidases. Brain Res 539:239-246.
25. May LJ, Wightman RM (1989) Heterogeneity of stimulated dopamine overflow within rat striatum as observed with m vivo voltammetry. Brain Res 487:311-320.
26. 3H-GBR 12935. J Neural Transm 87:1-14.
27. Morrison JH, Molliver ME, Grzanna R, Coyle JT (1979) Noradrenergic innervation patterns in three regions of medial cortex: an immunofluorescence characterization. Brain Res Bull 4:849-857.
28. 3H]GBR-12935 binding proteins. Arch Biochem Biophys 276:424-432.
29. Niznik HB, Fogel EF, Fassos FF, Seeman P ( 1991 ) The dopamine transporter is absent in parkinsonian putamen and reduced in the caudate nucleus. J Neurochem 56:192-198.
30. Olson L, Seiger A, Fuxe K (1972) Heterogeneity of striatal and limbic dopamine innervation: highly fluorescent islands in developing and adult rats. Brain Res 44:283-288.
31. Patel A, Uhl G, Kuhar MJ (1993) Species differences in dopamine transporters: postmortem changes and glycosylation differences. J Neurochem 61:496-500.
32. Pickel VM, Beckley SC, Joh TH, Reis DJ (1981) Ultrastructural immunocytochemical localization of tyrosine hydroxylase in the neostriatum. Brain Res 225:373-385.
33. Pifl C, Giros B, Caron MG (1993) Dopamine transporter expression confers cytotoxicity to low doses of the parkinsonism-inducing neurotoxin 1-methyl-4-phenylpyridinium. J Neurosci 13:4246-4253.
34. 3H]GBR 12,935 binding. Mol Pharmacol 45:125-135.
35. 3H]GBR 12935: binding characteristics. Brain Res 540:1-13.
36. Shimada S, Kitayama S, Walther D, Uhl G (1992) Dopamine transporter mRNA: dense expression in ventral midbrain neurons. Brain Res Mol Brain Res 13:359-362.
37. Silbergeld EK, Walters JR (1979) Synaptosomal uptake and release of dopamine in substantia nigra: effects of gamma-aminobutyric acid and substance P. Neurosci Lett 12:119-126.
38. Simon JR, Ghetti B (1993) Is there a significant somatodendritic uptake of dopamine in the substantia nigra? Evidence from the weaver mutant mouse. Neurochem Int 22:471-477.
39. Singer HS, Hahn IH, Moran TH (1991) Abnormal dopamine uptake sites in post-mortem striatum from patients with Tourette's syndrome. Ann Neurol 30:558-562.
40. Smith DB, Johnson KS (1988) Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase. Gene 67:31-40.
41. Tyndale RF, Sunahara R, Inaba T, Kalow W, Gonzalez FJ, Niznik HB (1991) Neuronal cytochrome P450IID1 (debrisoquine/sparteine-type): potent inhibition of activity by (-)-cocaine and nucleotide sequence identity to human hepatic P450 gene CYP2D6. Mol Pharmacol 40:63-68.
42. Vandenbergh DJ, Persico AM, Uhl GR (1992) A human dopamine transporter cDNA predicts reduced glycosylation, displays a novel repetitive element and provides racially-dimorphic TaqI RFLPs. Brain Res Mol Brain Res 15:161-166.
43. Vaughan RA, Uhl G, Kuhar MJ (1993) Recognition of dopamine transporters by antipeptide antibodies. Mol Cell Neurosci 4:209-215.
44. Voorn P, Buijs RM (1987) Ultrastructural demonstration of dopamine in the central nervous system. In: Monoaminergic neurons: light microscopy and ultrastructure (Steinbusch HWM, ed), pp 241-264. New York: Wiley.
45. Voorn P, Kalsbeek A, Jorritsma BB, Groenewegen HJ (1988) The preand postnatal development of the dopaminergic cell groups in the ventral mesencephalon and the dopaminergic innervation of the striatum of the rat. Neuroscience 25:857-887.
46. Yokoyama C, Okamura H, Ibata Y (1993) Resistance of hypothalamic dopaminergic neurons to neonatal 6-hydroxydopamine toxicity. Brain Res Bull 30:551-559.
47. Zigmond MJ, Abercrombie ED, Berger TW, Grace AA, Stricker EM (1990) Compensations after lesions of central dopaminergic neurons: some clinical and basic implications. Trends Neurosci 13:290-296.